Receptor occupancy, the ratio between amount of drug bound and amount of total receptor on single cells, is a biomarker for treatment response to therapeutic monoclonal antibodies. Receptor occupancy is traditionally measured by flow cytometry. However, spectral overlap in flow cytometry limits the number of markers that can be measured simultaneously. This restricts receptor occupancy assays to the analysis of major cell types, although rare cell populations are of potential therapeutic relevance. We therefore developed a receptor occupancy assay suitable for mass cytometry. Measuring more markers than currently available in flow cytometry allows simultaneous receptor occupancy assessment and high‐parameter immune phenotyping in whole bloo...
Antibody-dependent cellular cytotoxicity (ADCC) is one of the important mechanisms of action of the ...
Mass cytometry is a powerful tool that allows simultaneous analysis of more than 37 markers at the s...
Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting mul...
Receptor occupancy, the ratio between amount of drug bound and amount of total receptor on single ce...
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FC...
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FC...
We report the development and validation of a 12 parameter immunofluorescence flow cytometry method ...
ABSTRACTReceptor occupancy assays applied in clinical studies provide insights into pharmacokinetic-...
Nanosensor-based detection of biomarkers can improve medical diagnosis; however, a critical factor i...
<div><p><i>N</i>-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune neurological dise...
N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune neurological disease, diagnosed ...
Reversible binding, for example between signaling molecules and receptors on the cell surface, is on...
High resolution measurement characterizing the large number of cellular features is in the focus of ...
<div><p>Mass cytometry is a powerful tool that allows simultaneous analysis of more than 37 markers ...
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FC...
Antibody-dependent cellular cytotoxicity (ADCC) is one of the important mechanisms of action of the ...
Mass cytometry is a powerful tool that allows simultaneous analysis of more than 37 markers at the s...
Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting mul...
Receptor occupancy, the ratio between amount of drug bound and amount of total receptor on single ce...
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FC...
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FC...
We report the development and validation of a 12 parameter immunofluorescence flow cytometry method ...
ABSTRACTReceptor occupancy assays applied in clinical studies provide insights into pharmacokinetic-...
Nanosensor-based detection of biomarkers can improve medical diagnosis; however, a critical factor i...
<div><p><i>N</i>-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune neurological dise...
N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune neurological disease, diagnosed ...
Reversible binding, for example between signaling molecules and receptors on the cell surface, is on...
High resolution measurement characterizing the large number of cellular features is in the focus of ...
<div><p>Mass cytometry is a powerful tool that allows simultaneous analysis of more than 37 markers ...
Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FC...
Antibody-dependent cellular cytotoxicity (ADCC) is one of the important mechanisms of action of the ...
Mass cytometry is a powerful tool that allows simultaneous analysis of more than 37 markers at the s...
Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing-remitting mul...